KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Axt (AXTI) Research & Development (2016 - 2025)

Axt (AXTI) has disclosed Research & Development for 15 consecutive years, with $2.4 million as the latest value for Q4 2025.

  • Quarterly Research & Development fell 42.1% to $2.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.0 million through Dec 2025, down 37.78% year-over-year, with the annual reading at $9.0 million for FY2025, 37.78% down from the prior year.
  • Research & Development hit $2.4 million in Q4 2025 for Axt, up from $1.0 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $4.1 million in Q4 2024 to a low of $1.0 million in Q3 2025.
  • Historically, Research & Development has averaged $3.0 million across 5 years, with a median of $3.0 million in 2023.
  • Biggest five-year swings in Research & Development: soared 70.93% in 2021 and later crashed 70.54% in 2025.
  • Year by year, Research & Development stood at $2.8 million in 2021, then skyrocketed by 32.83% to $3.7 million in 2022, then fell by 22.99% to $2.8 million in 2023, then skyrocketed by 46.56% to $4.1 million in 2024, then tumbled by 42.1% to $2.4 million in 2025.
  • Business Quant data shows Research & Development for AXTI at $2.4 million in Q4 2025, $1.0 million in Q3 2025, and $2.5 million in Q2 2025.